PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive non-viral vectorized gene therapies with minimally-invasive delivery technology, has reported the ...

According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...

PulseSight Therapeutics has unveiled positive phase 1 results for PST‑611, its non‑viral gene therapy candidate for dry ...

Share on Pinterest A formulation of over-the-counter antioxidant supplements may help prevent the progression of dry age-related macular degeneration, a new study finds. filmstudio/Getty Images Dry ...

Please provide your email address to receive an email when new articles are posted on . Female smokers had a greater visual acuity decline than male smokers. Hypertension, diabetes and number of ...

Whatever your stage of age-related macular degeneration, Joshua L. Dunaief, MD, PhD, says that you can minimize its damage. Here’s how. Put a random sampling of 100 older Americans into a room and you ...

Stealth BioTherapeutics (the "Company" or "Stealth"), a commercial-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

“For more than 25 years, Alcon has been a leader in vitreoretinal surgery, and we are excited to expand our offerings into the clinic, to help millions of people living with dry AMD gain vision,” said ...

MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas, announced positive results from its Phase II ...

Age-related macular degeneration (AMD) is a leading cause of vision loss among people aged 50 and older. While treatments for the wet form of AMD have shown promise, the dry form, which accounts for ...

Wet age-related macular degeneration advances much more rapidly than the dry form, potentially causing significant vision decline within days to weeks without treatment. Anti-VEGF injections ...